Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M313392200 on May 20, 2004

J. Biol. Chem., Vol. 279, Issue 31, 32524-32533, July 30, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/31/32524    most recent
M313392200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenkilde, M. M.
Right arrow Articles by Schwartz, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenkilde, M. M.
Right arrow Articles by Schwartz, T. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The CXC Chemokine Receptor Encoded by Herpesvirus saimiri, ECRF3, Shows Ligand-regulated Signaling through Gi, Gq, and G12/13 Proteins but Constitutive Signaling Only through Gi and G12/13 Proteins*

Mette M. Rosenkilde{ddagger}, Katherine A. McLean, Peter J. Holst, and Thue W. Schwartz

From the Laboratory for Molecular Pharmacology, Department of Pharmacology, the Panum Institute, University of Copenhagen, 2200 Copenhagen N, Denmark

Open reading frame 74 (ORF74) of many {gamma}2 -herpesviruses encodes a CXC chemokine receptor. The molecular pharmacological profile of ORF74 from herpesvirus saimiri, ECRF3, is characterized here and compared with that of the well known ORF74 from human herpesvirus 8 (HHV8). The ECRF3 receptor bound the so-called ELR (Glu-Leu-Arg) CXC chemokines 125I-CXCL1/GRO{alpha}, 125I-CXCL6/GCP-2, and 125I-CXCL8/interleukin-8 with high affinity; but in contrast to ORF74 from HHV8, it did not bind the non-ELR CXC chemokine 125I-CXCL10/IP10. Interestingly, the Bmax value for CXCL6/GCP-2 was 3-fold higher than the capacity for maximal binding of CXCL1/GRO{alpha} to ECRF3 and 85-fold higher than that of CXCL8/interleukin-8, despite similar affinities. Like ORF74 from HHV8, ECRF3 activated a broad range of pathways (Gq, Gi, and G12/13 as well as the cAMP response element-binding protein, NF-{kappa}B, NFAT, and serum response element transcription factors) in a ligand-regulated manner, with CXCL6/GCP-2 being the most potent and efficacious agonist. ECRF3 signaled constitutively through Gi and G12/13, but surprisingly not through Gq. At the level of transcription factor activation, the serum response element was activated constitutively by ECRF3, whereas cAMP response element-binding protein, NFAT, and NF-{kappa}B were only ligand-regulated. The maximal signaling capacities were similar for the two receptors; however, the ligand-regulated signaling was responsible for the major part of the total ECRF3 signaling and only for a minor part of the total HHV8 ORF74 signaling. The activation pattern of ECRF3 with constitutive activation of some (but not all) of the employed pathways has not been seen before in endogenous or virus-encoded chemokine receptors. The results suggest that the unique ligand selectivity of ECRF3 among ORF74 receptors could reflect differences in the cellular tropism of the {gamma}2-herpesviruses.


Received for publication, December 8, 2003 , and in revised form, May 14, 2004.

* This work was supported by grants from the Danish Medical Council, the Danish Cancer Foundation, and the NovoNordisk Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Lab. for Molecular Pharmacology, Dept. of Pharmacology, Panum Inst., Bldg. 18.6, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen N, Denmark. Tel.: 45-3532-7608; Fax: 45-3532-7610; E-mail: rosenkilde{at}molpharm.dk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
R. Case, E. Sharp, T. Benned-Jensen, M. M. Rosenkilde, N. Davis-Poynter, and H. E. Farrell
Functional Analysis of the Murine Cytomegalovirus Chemokine Receptor Homologue M33: Ablation of Constitutive Signaling Is Associated with an Attenuated Phenotype In Vivo
J. Virol., February 15, 2008; 82(4): 1884 - 1898.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. I. Abdullah, P. L. Pedraza, J. C. McGiff, and N. R. Ferreri
CaR activation increases TNF production by mTAL cells via a Gi-dependent mechanism
Am J Physiol Renal Physiol, February 1, 2008; 294(2): F345 - F354.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
E. L. Sharp, H. E. Farrell, K. Borchers, E. C. Holmes, and N. J. Davis-Poynter
Sequence analysis of the equid herpesvirus 2 chemokine receptor homologues E1, ORF74 and E6 demonstrates high sequence divergence between field isolates
J. Gen. Virol., September 1, 2007; 88(9): 2450 - 2462.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. M. Rosenkilde, R. David, I. Oerlecke, T. Benned-Jensen, U. Geumann, A. G. Beck-Sickinger, and T. W. Schwartz
Conformational Constraining of Inactive and Active States of a Seven Transmembrane Receptor by Metal Ion Site Engineering in the Extracellular End of Transmembrane Segment V
Mol. Pharmacol., December 1, 2006; 70(6): 1892 - 1901.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Verzijl, L. Pardo, M. van Dijk, Y. K. Gruijthuijsen, A. Jongejan, H. Timmerman, J. Nicholas, M. Schwarz, P. M. Murphy, R. Leurs, et al.
Helix 8 of the Viral Chemokine Receptor ORF74 Directs Chemokine Binding
J. Biol. Chem., November 17, 2006; 281(46): 35327 - 35335.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
L. Li and K. A. Borkovich
GPR-4 Is a Predicted G-Protein-Coupled Receptor Required for Carbon Source-Dependent Asexual Growth and Development in Neurospora crassa.
Eukaryot. Cell, August 1, 2006; 5(8): 1287 - 1300.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. M. Rosenkilde, T. Benned-Jensen, H. Andersen, P. J. Holst, T. N. Kledal, H. R. Luttichau, J. K. Larsen, J. P. Christensen, and T. W. Schwartz
Molecular Pharmacological Phenotyping of EBI2: AN ORPHAN SEVEN-TRANSMEMBRANE RECEPTOR WITH CONSTITUTIVE ACTIVITY
J. Biol. Chem., May 12, 2006; 281(19): 13199 - 13208.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. P. Fitzsimons, U. A. Gompels, D. Verzijl, H. F. Vischer, C. Mattick, R. Leurs, and M. J. Smit
Chemokine-Directed Trafficking of Receptor Stimulus to Different G Proteins: Selective Inducible and Constitutive Signaling by Human Herpesvirus 6-Encoded Chemokine Receptor U51
Mol. Pharmacol., March 1, 2006; 69(3): 888 - 898.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. M. Rosenkilde, T. N. Kledal, and T. W. Schwartz
High Constitutive Activity of a Virus-Encoded Seven Transmembrane Receptor in the Absence of the Conserved DRY Motif (Asp-Arg-Tyr) in Transmembrane Helix 3
Mol. Pharmacol., July 1, 2005; 68(1): 11 - 19.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement